|
|
|
Volumn 17, Issue 4, 1999, Pages 275-282
|
|
Magnetic resonance imaging (MRI) and technetium-99m-methoxyisonitrile (MIBI) scintigraphy to evaluate the abnormal parathyroid gland and PEIT efficacy for secondary hyperparathyroidism
a
a
|
|
Author keywords
99mTc MIBI scintigraphy; Chronic renal failure; MRI; Parathyroid; Parathyroid hyperplasia; PEIT; Ultrasonography
|
|
Indexed keywords
ALCOHOL;
METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;
PARATHYROID HORMONE;
ADULT;
AGED;
ARTICLE;
B SCAN;
BIOACCUMULATION;
CHRONIC KIDNEY FAILURE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
DRUG EFFICACY;
FEMALE;
HEMODIALYSIS;
HUMAN;
IMAGE ANALYSIS;
INTERMETHOD COMPARISON;
MALE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
ORGAN SIZE;
PARATHYROID HORMONE BLOOD LEVEL;
PARATHYROID SCINTISCANNING;
SCLEROTHERAPY;
SECONDARY HYPERPARATHYROIDISM;
TRANSDERMAL DRUG ADMINISTRATION;
TREATMENT OUTCOME;
VALIDATION PROCESS;
ADULT;
AGED;
ETHANOL;
FEMALE;
HUMANS;
HYPERPARATHYROIDISM, SECONDARY;
INJECTIONS;
KIDNEY FAILURE, CHRONIC;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
PARATHYROID GLANDS;
RADIOPHARMACEUTICALS;
SENSITIVITY AND SPECIFICITY;
TECHNETIUM TC 99M SESTAMIBI;
TREATMENT OUTCOME;
|
|
EID: 0032879108
PISSN: 02882043
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (9)
|
|
References (31)
|
